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We study the influence of the rate of the attainment of herd immunity (HI), in the absence of
an approved vaccine, on the vulnerable population. We essentially ask the question: how hard the
evolution towards the desired herd immunity could be on the life of the vulnerables? We employ
mathematical modelling (chemical network theory) and cellular automata based computer simu-
lations to study the human cost of an epidemic spread and an effective strategy to introduce HI.
Implementation of different strategies to counter the spread of the disease requires a certain degree
of quantitative understanding of the time dependence of the outcome. In this paper, our main
objective is to gather understanding of the dependence of outcome on the rate of progress of HI.
We generalize the celebrated SIR model (Susceptible-Infected-Removed) by compartmentalizing the
susceptible population into two categories- (i) vulnerables and (ii) resilients, and study dynamical
evolution of the disease progression. We achieve such a classification by employing different rates of
recovery of vulnerables vis-a-vis resilients. We obtain the relative fatality of these two sub-categories
as a function of the percentages of the vulnerable and resilient population, and the complex depen-
dence on the rate of attainment of herd immunity. Our results quantify the adverse effects on the
recovery rates of vulnerables in the course of attaining the herd immunity. We find the important
result that a slower attainment of the HI is relatively less fatal. However, a slower progress towards
HI could be complicated by many intervening factors.
I. INTRODUCNTION
The present COVID-19 pandemic is a dynamic and
volatile process with often unpredictable ups and downs
in the infected populations that make it difficult to pre-
dict its future course. In the absence of any vaccine
or definitive drug in the immediate future [1] the fight
against COVID-19 is a hard and long drawn bitter bat-
tle, with two strategies being put forward. The first is
the widely enforced lockdown, quarantine, and social dis-
tancing where the spread of the disease is contained at
its inception and only a limited fraction of population
is allowed to be infected.[2] This model appears to be
successful in South Korea and China, and some other
Asian countries.[3] The other model is to allow the virus
to have a relatively unconstrained transmission so that
a large fraction of the people develops the immunity.[4]
This is called the herd immunity (HI) that is favoured
by Sweden, and was initially discussed by Germany and
England, but largely discarded later. HI can be achieved
by two ways- (i) by vaccination, and (ii) by infection.
The HI approach is based on the understanding that one
can obtain the herd immunity in the society if 60-70% of
the population gets immunized. Needless to say this herd
immunity is preferable through vaccination as happened
in small pox and measles. Implementation of both the
models has difficulties. Implementation of lockdown and
social distancing requires enormous effort, backed up by
resources. On the other hand, the HI model could have
adverse consequence on the vulnerable citizens, a subject
not adequately discussed. In fact, experiences in Italy
and Spain show that the demography can be altered in
some regions if HI is given an unconstrained run.
Herd immunity ensures an indirect protection from
COVID-19 (or any other infectious disease) when a large
fraction of the population becomes immunized to the
disease.[5–7] Herd immunity drastically decreases the
probability of the presence of an uninfected individual
in the vicinity of a presently infected individual. That
is, the infected person is effectively quarantined by the
surrounding immunized population. Hence, the chain of
propagation breaks. In Fig. 1 we pictorially explain the
phenomenon of herd immunity.
FIG. 1. A pictorial representation of the herd immunity phe-
nomenon. In the left we have a region with the susceptible
population and one infected person. The total susceptibles
are further divided into vulnerables and resilients. The in-
fection propagates in an unconstrained manner and after a
certain period the region possesses a large fraction of immu-
nized population (right). After this immunisation any further
infection cannot propagate and indirectly protects the suscep-
tibles. In addition to that, multiple infected persons cannot
do further harm. The colour codes are maintained throughout
this paper.
This can happen by providing the population with a
vaccine or by getting cured after being infected. In the
case of COVID-19 pandemic, as of now, we are unsure
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2regarding the success of a vaccine and the latter is the
only option to attain HI. However, the herd immunity
threshold (HIT), that is the minimum fraction of popu-
lation needs to get immunized in order to eradicate the
disease, is different for different infectious diseases.[8, 9]
For example, HIT for measles is 92-95% and for that of
SARS-1 it is in the range of 50-80%.
Researchers around the world are exploring mainly
two aspects of this disease- (i) the microscopic and clin-
ical aspects which would eventually lead to drug dis-
covery and vaccine preparation,[1, 10] (ii) the demo-
graphic aspects which lead to policy making and time-
line prediction.[2, 3, 11, 12] The latter requires effective
mathematical modelling and crowd simulations. How-
ever, these models fail to predict the real scenario be-
cause of some inherent assumptions and limitations. Al-
though a lot of interesting new studies are emerging in
both categories in the context of the recent coronavirus
pandemic, the issue of herd immunity and its fatality are
not studied.
There are several mathematical models which have
been employed in the context of epidemic modelling, for
example, the famous Kermack-McKendrick (KM) model
which has been used extensively to study the spread of
infectious diseases like measles, small pox etc.[13, 14] At
the core of this model lies a system of three coupled dif-
ferential equations for susceptible (S), infected (I) and
removed (R) (cured and dead) populations, that is, the
famous SIR model (Eq. 1).[15–17] At the onset of an
epidemic S becomes I and I eventually becomes R, but R
can never become S or I because of acquired immunity.
dS
dt
= −kS→ISI
dI
dt
= kS→ISI − kI→RI
dR
dt
= kI→RI
(1)
Eq. 1 describes the three coupled non-linear differen-
tial equations of the KM model where kS→I is the rate of
infection and kI→R is the rate of removal (recovery and
death). In the conventional SIR model kS→I and kI→R
are written as α and β respectively. In principle the rate
constants should be time and space dependent, that is,
non-local in nature. But it is difficult to predict the func-
tional form of the rate constants with time- it could be
periodic, decaying or stochastic in nature. The appli-
cability of this model is for a homogeneous population
distribution and mass transmission at a large scale.[13]
An important quantity is the basic reproduction num-
ber (R0) which is an estimate of the number of secondary
infection from one primary infection.[18] The value of R0
is intimately connected with the herd immunity thresh-
old (Ht) discussed above.[9, 19] (Eq. 2) Hence a correct
determination of the basic reproduction parameter, R0,
is important.
Ht =
(
1− 1
R0
)
× 100% (2)
It is clear from Eq. 2 that a higher value of R0 in-
creases the herd immunity threshold. For SARS-Cov2
the value of R0 shows a large dispersion and as a conse-
quence we cannot predict the value of Ht. For COVID-19
the average value of R0 is estimated to be in the range
of ∼2.0-3.0 but it can possess spatial heterogeneity and
time dependence in reality.[20, 21] If one considers R0 to
be in the range of 2.0-3.0 the value of Ht would be in
between 50%-66%.
In the light of SIR model [Eq.(1)] R0 can be defined as
R0 =
kS→I
kI→R
S (3)
Eq. 3 provides a different definition of R0 and can
be understood as follows. If we assume that (the S the
fraction of susceptible population) is near 1.0 at the be-
ginning (as there are very few infections compared to a
huge population), then R0 could be equal to unity if the
two rate constants are equal. This means that the num-
ber of infection and recovery are same at any time. In
this situation the disease remains under control. R0 > 1
causes an epidemic as it challenges the capacity of the
healthcare facilities. However, for different region the
value of R0 could be different depending on the intensity
of region wise preventive and healthcare measures.
In this work we ask the following questions- (i) what
are the relative magnitude of the fatality to the vulnera-
ble and resilient populations if we attempt to achieve HI
without a vaccine? (ii) What is the dependence of the
fraction of survival on the rate of the attainment of HI?
These two issues are widely discussed all over the world.
Here we seek answers to these two important questions
by employing a modified Susceptible-Infected-Removed
(SIR) model and cellular automata (CA) simulations.
The rest of the paper is organised as follows. In sec-
tion II we describe the mathematical model and the CA
simulation protocols. Section III consists of the results
from numerical solutions of the modified SIR model and
simulations, accompanied by detailed discussions. This
section is further divided into several sub sections. In
section IV we summarize and conclude our study.
II. THEORETICAL FORMALISM
A. Mathematical Modelling
We modify the celebrated SIR (Susceptible-Infected-
Removed) model by dividing the entire susceptible pop-
ulation into two parts, namely vulnerable (Vul) and re-
silient (Res). In the context of the corona virus dis-
ease, the vulnerable category consists of persons who
3are above 60 years of age or have pre-existing medical
conditions like diabetes, heart and kidney disease, and
lung conditions.[22] The rest of the population is termed
as resilient who have a greater chance of getting cured.
We achieve such classification by employing different rate
constants associated with their recovery. This is based
on the available data on the coronavirus disease. The
scheme of this classification is described in Fig. 2.
FIG. 2. Schematic representation of the modified SIR net-
work model. Here the susceptible (S) population is divided
into SV and SR that represent elderly and younger people re-
spectively. A part of the fraction SV gets infected and creates
IO fraction of infected population. A part of the remaining
fraction of the population, that is, SR gets infected and cre-
ates IR fraction of the infected population. Both IV and IR
get either cured (C) or dead (D). Naturally the rate of recov-
ery for the younger fraction of the population is more than
that of the older infected population. On the other hand, the
rate of death for the older population is more than that of the
younger invectives.
We follow the scheme described in Fig. 2 and formulate
a system of eight coupled non-linear differential equations
[Eqs. 4 - 11].
dSV ul(t)
dt
= −kSV ul→IV ul(t)SV ul(t)I(t) (4)
dSRes(t)
dt
= −kSRes→IRes(t)SRes(t)I(t) (5)
dIV ul(t)
dt
= kSV ul→IV ul(t)SV ul(t)I(t)
−(kIV ul→CV ul(t) + kIV ul→DV ul(t))IV ul(t)
(6)
dIRes(t)
dt
= kSRes→IRes(t)SRes(t)I(t)
−(kIRes→CRes(t) + kIRes→DRes(t))IRes(t)
(7)
dCV ul(t)
dt
= kIV ul→CV ul(t)IV ul(t) (8)
dCRes(t)
dt
= kIRes→CRes(t)IRes(t) (9)
dDV ul(t)
dt
= kIV ul→DV ul(t)IV ul(t) (10)
dDRes(t)
dt
= kIRes→DRes(t)IRes(t) (11)
In the following, we explain the complex set of equa-
tions. Here I(t) is the number of total infectives at any
time t, that is I(t) = IV ul(t) + IRes(t). This is the vari-
able that couples the two population sub-categories. k(t)
are the rate constants associated with processes that are
described in the subscript with an arrow.
We would like to point out that the rates in above
equations of motion are all assumed to be time depen-
dent. These rate constants contain all the basic informa-
tion and also connected with R0. In our earlier study,
we employed a time dependent rate to produce certain
features observed in the time dependence of new cases
such a double peaked population structure.[12] The time
dependence of rate can be employed to include certain
dynamical features like crossover from local contact to
community transmission. It is worth stressing that the
modelling of these time dependent rate constants plays a
pivotal role in the SIR scheme.
We propagate these equations numerically to obtain
the respective temporal evolution of each kind of popula-
tion fraction. From the temporal profiles we can extract
several important quantities after a long time (that is,
the end of the spread), for example, (i) the peak height
of the active infected cases, (ii) the fraction of cured pop-
ulation, (iii) the fraction of dead population, (iv) the frac-
tion of uninfected population, (v) time required to reach
the immunity threshold etc. We can regard these equa-
tions together to form a system of reacting species, as in
a system of chemical reactions.
We solve these equations with two different sets of the
rate constant values and aim to understand the relative
damages to the vulnerable and resilient population. The
values of rate constants are provided in Table I. We keep
kSV ul→IV ul and kSRes→IRes the same which depicts the
same probability of getting infected for both the sub-
categories. However, the rate constants associated with
recovery and death differs in orders of magnitude between
Vul and Res.
We now discuss the procedure we follow to assign dif-
ferent rate constants to the vulnerables and resilients. In
a previous study we estimated the values of kS→I and
kI→R by fitting the infected/cured/death vs. time data
for India (source: www.covid19india.org).[12] We plot
the rate of change of the cured (dC/dt) and dead (dD/dt)
population against the infected population to find the
slope that gives the rate. This procedure provides us with
required estimates of kI→C and kI→D. For India, till 27th
May, the estimated values are kI→C = 0.026 day−1 and
kI→D = 0.0013day−1. That is, kI→C is approximately 20
times of kI→D. However, for countries like Italy, Spain,
4and USA kI→D was significantly higher. This compari-
son however takes no cognition of the relative time scales,
and therefore should be taken with care.
These values are mean field in nature and contain enor-
mous spatial heterogeneity. If we see the state wise (or
district wise) statistics we find a large dispersion. On
the other hand, the determination of kS→I is not that
straight forward as the equations containing kS→I are
non-linear in nature in the SIR model. Hence one needs
to obtain a good estimate of R0 and calculate kS→I from
Eq. 3. As mentioned above, R0 also exhibits spatiotem-
poral heterogeneity which makes the problem of estimat-
ing the rate constants even more challenging. For exam-
ple, in Italy R0 has been estimated to be ∼3.0-6.0 and
in the Hunan province of China it is ∼1.73-5.25.[23] In a
recent study on Wuhan, the transmission rate (kS→I) is
assumed to vary from 0.59 to 1.68 day−1.[24]
However, the data required to extract the rate con-
stants associated with the two individual sub-categories,
namely, vulnerable and resilient, are not available sepa-
rately. As the values of the rate constants are connected
to the basic reproduction number (R0), we choose the
inputs, by preserving the basic features, such that the
average value of R0 yields an acceptable number, in light
of acquired information. Next we tune the parameters
such that the maximum of the active cases falls in the
range of ∼60-90 days, as observed for most countries.
We note that we consider these values only to study the
trends and do not strictly correspond to any particular
region in reality.
TABLE I. The values of rate constants used to solve the sys-
tem of coupled differential equations [Eq.4 - 11]. The unit of
the rate constants is day−1.
Rate Const. Set-1 Set-2
kSV ul→IV ul 0.50 0.78
kIV ul→CV ul 0.05 0.05
kIV ul→DV ul 0.10 0.10
kSRes→IRes 0.50 0.78
kIRes→CRes 0.50 0.50
kIRes→DRes 0.05 0.05
We invoke two different values of R0 for the two dif-
ferent sub-categories. For set-1 RV ul0 = 3.33 and R
Res
0 =
3.33. The larger value of R0 for vulnerables arise from
slower rate of recovery, Eq. 3.
On the other hand, for set-2 RV ul0 = 5.20 and R
Res
0 =
1.42. We obtain these values by considering each of the
population to be individually normalised (that is 100%).
In such a situation the effective R0 can be calculated as
follows (Eq. 12).
Reff0 =
RV ul0 NV ul +R
Res
0 NRes
NV ul +NRes
(12)
Here NV ul and NRes represent the number of people in
the vulnerable and resilient category respectively. In all
our calculations we start with total infected fraction as
0.001 and vary the percentage of vulnerable populations
from 5%-40%. By using Eq. 12 we calculate the effec-
tive R0 values for different ratio of vulnerable to resilient
population. We find R0 varies from 1.03 to 1.88 for set-1
and 1.61 to 2.93 for set-2. In a way, set-1 represents a
more controlled situation compared to set-2 (Table II).
TABLE II. The basic reproduction number (R0) for the pa-
rameters described in Table I (set-1 and set-2) for various
ratios of vulnerable to resilient population.
% % R0
vulnerble resilient Set-1 Set-2
5 95 1.031 1.609
10 90 1.152 1.798
15 85 1.273 1.987
20 80 1.394 2.176
25 75 1.515 2.365
30 70 1.636 2.554
35 65 1.757 2.743
40 60 1.878 2.932
B. Stochastic Cellular Automata Simulation
Stochastic cellular automata (CA) simulations give a
microscopic and nonlocal picture of the problem at hand.
Such simulations are often used to model several physical
phenomena.[25–31] Unlike the mathematical model, CA
simulations can directly establish a physical map of the
disease-spread. Moreover, we incorporate several region
specific and disease specific parameters in our CA simu-
lations that give a general outlook to our investigations.
A detailed list of the parameters and associated symbols
can be found in our previous work.[12]
The spread of COVID-19 is strongly inhomogeneous.
So, a homogeneous model fails to capture many aspects.
In a real-world scenario, the non-local description may of-
ten become important in determining the fate of a pan-
demic in a given geographical region. In such a case,
the population parameters are space-dependent. More-
over, the rate constants also have a spatial distribution.
Hence, solutions of these equations are highly non-trivial
and a large scale cellular automata simulation may cap-
ture these inherent spatiotemporal heterogeneities.
In this work, we neglect the effects of social distancing
and quarantine, since we aim at establishing a relation
between the percentage of mortality and immunization
by an unhindered transmission of the disease within the
whole population. Calculation of the rates of transmis-
sion and recovery/death can often be difficult due to sev-
eral reasons like unavailability of data, political or de-
mographic complications etc. This becomes particularly
nontrivial when we consider the process with respect to a
given population distribution of vulnerable and resilient
5individuals. The probabilistic approach employed in our
simulations makes it easier to study the process, since ob-
taining an average probability for each of the processes
is much more practical.
We use the Moore definition [32–34] to denote the
neighbourhood of a given person. The salient features
of our simulation are detailed in our previous work.[12]
Here, we summarize our CA simulation methodology.
We start we a land randomly occupied by susceptibles
and infectives. The population distribution is such that
5% and 0.05% of the total available land is covered by sus-
ceptibles and infectives respectively. We divide the pop-
ulation into vulnerable and resilient individuals with re-
spect to their probabilities of recovery (PV ulR and P
Res
R ).
Vulnerables primarily include people above the age of 60.
This also includes people with serious health issues, who
are more prone to get deceased if infected.[35–37] The re-
silients, on the other hand, are the young fraction of the
society with no severe health conditions. When an in-
fective comes in the neighbourhood of a susceptible, the
latter is converted to an infective with a given probabil-
ity of transmission which is considered to be equal and
time independent (constant) for both vulnerables and re-
silients. The time period of infection is determined by
probability of recovery and the probability of remaining
infected in a given simulation step. In this work, we con-
sider the latter to be 0.99.[12] An individual, once cured
from infection, becomes immune to the disease.
We run our simulations for a given number of steps
(N). It should be noted that the time unit is not well-
defined for this simulations. To get an estimate of time,
the results need to be compared with our theoretical
model.
III. RESULTS AND DISCUSSION
A. Numerical solutions of the SIR model
Here we present the results from the numerical solu-
tions of Eqs. 4 - 11 in Fig. 3. We choose two sets of
rate constants, set-1 (Fig. 3a) and set-2 (Fig. 3b) and
obtain the changes in the population of vulnerables and
resilients. With our choice of parameters (Table I) for
set-1 we observe 40.8% increase in the immuned popula-
tion. In order to achieve the 40.8% immunity a region
loses 4.7% of its resilient population and 34.3% vulnera-
ble population. On the other hand, for set-2 a region loses
7.9% of its resilient population and 57.1% of its vulnera-
ble population in order to achieve ∼68% immunity (that
could be the HIT for COVID-19). Hence, it is clear that
for both the two cases the vulnerables are significantly
affected. We note that with an increased infection rate
the timescale of the saturation of the temporal profiles
are drastically reduced. The graphs that are presented in
Fig. 3 are obtained for 20% initial vulnerable population.
In Fig. 4a, we show the time evolution of the total
immunity percentage. In order to study the effect of
FIG. 3. Population disease progression as obtained from the
solution of the system of eight coupled non-linear differential
equations presented in Eqs. 4 - 11 as function of time for
two different situations described in Table I. Plots show the
increase in the total immunity (blue) with the decrease in the
populations of vulnerable population (maroon) and resilient
population (green) for (a) Set-1 and (b) Set-2. In these two
calculations we start with V : R = 1 : 4. In both the two
cases the percentage demise in the vulnerable population is
significantly higher.
fast (early) vs slow (late) achievement of the immunity
saturation, we plot the percentage survival of the total
population against the time required to attain the im-
munity threshold (tIm) for different values of kS→I (Fig.
4b). We find that the percentage of survival increases
linearly with increasing tIm. This indicates that a quick
achievement of immunity saturation could lead to fatal
consequences. If a society opts for herd immunity, it has
to be a slow process.
FIG. 4. The effect of different rates of attaining herd immu-
nity on the total population. (a) Plot of the time evolution
of the percentage of total immunized population for differ-
ent values of susceptible to infected rate-constants. With in-
creasing kS→I we see an increase in the percentage immunity
and decrease the time required to reach saturation (tIm). (b)
Percentage survival (uninfected and cured population) of the
total population against tIm. The two quantities show linear
dependence. That is, the percentage survival increases as we
take more time to reach immunity saturation. Note that both
the X and the Y axes are the outcome of the numerical so-
lution and not provided as inputs. The calculations are done
using a fixed Vul:Res=1:4 and the rate constants associated
with recovery/death are also kept same as given in Table I.
To make the immunity gaining process slow (which
leads to relatively less casualty), the rate of infection
(kS→I) needs to be brought down. On the other hand,
6the rate of removal (recovery and death), kI→R, depends
primarily on the disease and partly on the presently avail-
able healthcare facilities. kS→I can be controlled by em-
ploying effective strategies like lockdown, quarantine, and
social distancing.
FIG. 5. The effect of the change in the initial percentage of
the vulnerable population on the relative infection and recov-
ery for the sub-categories, namely, vulnerables and resilients.
Plots show the dependence of infection peak, percentage cured
and dead population for vulnerable (maroon) and resilient
(green) population with the initial fraction of vulnerable pop-
ulation as obtained from the solution of the modified SIR
model described in Eqs. 4 - 11. For figures (a)-(c) set-1 and
for (d)-(f) set-2. The quantities show a non-linear dependence
and enhanced fatality for the vurnerables.
Next we vary the % of initial vulnerable population
from 5% to 40% and obtain the % of highest active cases
(that is the maxima in the temporal variation of IV (t) or
IR(t)), % of cured population and % of death. The range
is chosen in order to represent different regions/countries.
For example, in India only ∼ 8% of the entire population
is above 60 years whereas, in countries like Italy and
Germany the number is over 20%.
We obtain Fig. 5a - 5c for set-1 and Fig. 5d - 5f for
set-2. In both the cases the variation of the infected peak
maxima with % vulnerable shows nearly linear increase
with a higher slope for the vulnerables (Fig. 5a and 5d).
Interestingly the % cured (Fig. 5b and 5e) and % dead
(Fig. 5c and 5f) shows a nonlinear dependence on %
vulnerable. It clearly shows that the damage is huge
to the vulnerable population when the % of vulnerables
increases.
We plot (Fig. 6) the percentage of deaths for both the
subcategories against the herd immunity threshold for a
given Vul:Res composition (1:4). This is to show the in-
creasing damage with respect to Ht. We find that the
trend is linear for both the sets of parameters and the
relative fatality is substantially higher for the vulnera-
bles.
FIG. 6. Percentage outcome of different herd immunity
thresholds (Ht) on the vulberable and resilient population.
Plot of percentage deaths against Ht calculated from Eq. 2
for (a) set-1, and (b) set-2. In both the two cases the depen-
dence is linear with substantially more damage to the vulner-
able population. The values on the Y axes are individually
normalised.
B. (Stochastic Cellular Automata Simulations
1. Dependence on the initial population distribution
Here, we keep the probability of transmission of disease
time-independent and equal for both resilients and vul-
nerables. We change the initial fraction of the vulnerable
section of the total population from 5% to 40%. In Fig. 7
we plot the % of cured individuals (resilients and vulner-
ables) against % of total immunization when the tem-
poral progression of the population reaches saturation.
As discussed earlier, herd immunity is obtained when a
major section of the population becomes immune, post
infection. However, apart from gaining immunity, this
process involves the death of many infected individuals
according to their survival probability. The probability
of recovery of the resilients is higher than that of the vul-
nerables. Here, these two probabilities are taken as 0.95
and 0.8 respectively.[36, 38]
In Fig. 7 the abscissa is the percentage of the total
population that becomes immune after recovering from
the infection. The ordinate quantifies the percentage of
cured resilients and vulnerables with respect to the to-
tal initial population. With increase in the immunity
attained in the society, a significant decrease in the per-
centage of cured vulnerable individuals is observed. This
implies that higher the percentage of immunization in
7the total population, greater is the probability of death
of the vulnerable section. Hence herd immunity results
in the death of a major fraction of the vulnerable popu-
lation. This stratum of the society includes mainly the
old people (age greater than years) and people with se-
rious health conditions or comorbidity.[22, 39] The geo-
graphical regions with demographic distributions having
higher fraction of the people of age above ∼60 years are
among the worst affected. For example, Italy suffered
the loss of many aged people as a result of the COVID-
19 pandemic.[40, 41]
FIG. 7. Percentage of cured resilient and vulnerables in the
population on the course of attaining herd immunity. The
percentage of cured individuals is shown as a function of the
percentage of total population immunized after getting in-
fected. This is obtained by averaging over 100 CA simula-
tions. Green shows the percentage of death for the resilient
fraction of the society and maroon denotes the same for the
vulnerable people.
In Fig. 8a , we show the time evolution of the fraction
of vulnerables and resilients in the total population for
different % of initial number of vulnerables. The fractions
are calculated with respect to the total initial population.
We see that with increase in the initial % of vulnerables,
the number of resilients dying show a slight decrease,
whereas the number of dead vulnerables increases signif-
icantly. This observation is clarified in Fig. 8b. Here we
plot the absolute change in the fraction of resilients and
vulnerables as functions of the initial % of vulnerables.
Both show linear dependence. The gradient (slope) is
negative for resilients and positive for vulnerables. How-
ever, we find that the absolute value of the slope for the
latter is ∼5 times higher than that of the former. This
denotes that countries with higher population of elderly
and vulnerable people in the society incur a greater loss
in the number of vulnerable individuals.
FIG. 8. (a) Population dynamics represented as the temporal
evolution of the fraction of resilient and vulnerable sections of
the population are shown with varying initial distribution of
resilients and vulnerables. The colour bar on the right hand
side shows the initial % of vulnerables in the total population.
(b) The absolute decrease in the resilient (green) and vulner-
able (maroon) fractions of the total population as functions
of the initial percentage of vulnerables.
2. Dependence on the probability of recovery
Now, we keep the initial population distribution fixed
at 20% vulnerable and 80% resilient individuals. We
change the probability of recovery of these two categories
(PV ulR and P
Res
R ) with the constraint P
V ul
R ≤ PResR . Ac-
cordingly, we change these two probabilities from 0.6 to
0.8 and 0.8 to 0.95 respectively. We choose these values
according to reported case fatality ratios for the SARS-
CoV-2 pandemic.[36, 38]
FIG. 9. Interdependence of different fractions of the pop-
ulation as the immunity evolves. Percentage of immunized
(colour coded) represented as a function of the percentage
of survival for vulnerables and resilients. The proportions are
with respect to the total initial population. The primary vari-
ables are the probabilities of recovery of the vulnerables and
the resilients. The results are obtained after averaging over
100 simulations.
For every pair of PV ulR and P
Res
R we get a value of per-
centage of vulnerables and resilients who survive and a
fraction of the population that gets immunized. In Fig-
ure 9 we plot the survival % of vulnerables and resilients
8in the two perpendicular axes and represent the % immu-
nized as colour codes according to the colour gradation
bar on the right hand side. In this contour representa-
tion, red denotes low immunity and blue denotes higher
immunity.
The survival % of the vulnerables is lower than that of
the resilients. The percentage of immunized population
is higher (blue) for maximum survival of the resilients as
compared to that of the vulnerables. This means that to
attain higher immunity in the population, greater num-
ber of old and vulnerable people suffer death as compared
to resilients. Hence, attainment of herd immunity comes
with the cost of a higher mortality of the vulnerable sec-
tion of the society.
IV. SUMMARY AND CONCLUSION
Any epidemic is a dynamic process where time depen-
dence plays a crucial role in the control of the spread
and the damage, that is, the outcome. COVID-19 is a
pandemic which is currently under intense scrutiny by
all and sundry, and many aspects are yet to be under-
stood. Every move by the government, and the popula-
tion in general, is of crucial importance. Each pandemic
comes with unique characteristics that deserve special
treatments, not just medical and clinical but also socio-
logical. In each such epidemic, immunity plays a critical
role. Spanish Flu mainly attacked the age group between
20 and 30 years of age. This is the age group with max-
imum immunity. In the case of COVID-19, again we
face the sad reality that certain section of the society is
substantially more vulnerable than other sections. The
vulnerable section consists of age groups which are above
60-65 years of age, and people with comorbidity. There
is yet to further classification, although it is conceivable
that as we understand the disease better and more pre-
cisely, better perception of danger would emerge.
An epidemic often starts by a process of nucleation
which is an important phenomenon often studied in
physics and chemistry. The process of nucleation is initi-
ated by a sudden appearance of a group of infected indi-
viduals in a region. This may be triggered a laboratory
accident, or infection from eating wild animals like bats,
pangolin etc. or by arrival of infected tourists and so on.
The process may be dependent on the nature of the ge-
ography and demography of the country or region. The
initial period of the process is often slow. After the ini-
tial nucleation, the disease spreads by a diffusion process
into the susceptible population. Hence, it is a percolation
with a temporal evolution.
In order to address the issue of vulnerability of the
population and the outcome with the progression of the
epidemic, we carry out a theoretical analysis with the
objective to analyze the consequences of aiming for herd
immunity without vaccine, or a good drug, in the con-
text of the present COVID-19 pandemic. We develop
and solve a modified SIR model numerically and by em-
ploying cellular automata simulations. We particularly
probed the following question: what is dependence of
mortality on the rate of herd immunity?
One of the key results of the present study is the depen-
dence of the percentage survival on the rate of attainment
of the immunity threshold. We find that a late attain-
ment of the immunity saturation leads to relatively lesser
fatality. We show that approximately 50-60% of the vul-
nerables might lose their lives in order to attain 70%
total immunized population. On the contrary the mor-
tality of the resilient fraction of population is relatively
low, may be just about 10%. We find a non-linear trend
in the dependence of the cured and dead population on
the initial population of the vulnerables. This is because
as the number of vulnerables increases, the immunity by
infection from a larger fraction of population which can-
not protect the vulnerables unless deliberate efforts are
made that requires intervention.
While we discuss herd immunity by infection in this
work, the other, more sustainable option is herd immu-
nity by vaccination. For example, diseases like small pox,
polio etc. have been wiped off the face of earth by vacci-
nation. This is particularly crucial for diseases with high
mortality rates. However, for any novel disease, prepa-
ration of a vaccine can take years. In case of the present
COVID-19 pandemic, for instance, extensive research is
going on globally in search of a vaccine.[1] However, no
promising result has been obtained in almost five months
and researchers believe it may take more than a year to
prepare the vaccine.
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